Last reviewed · How we verify
NCT04998279
Intrauterine Infusion of GCSF and Reproductive Outcomes in Infertile Women with History of RIF
trial testing Granulocyte Colony-Stimulating Factor in Recurrent Implantation Failure in 100 participants. Completed in 25 September 2024.
30 August 2024
Quick facts
| Lead sponsor | Cairo University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 1 September 2019 |
| Primary completion | 30 August 2024 |
| Estimated completion | 25 September 2024 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Granulocyte Colony-Stimulating Factor
- placebo
Conditions studied
- Recurrent Implantation Failure — all drugs for Recurrent Implantation Failure →
- Granulocyte Colony-Stimulating Factor — all drugs for Granulocyte Colony-Stimulating Factor →
- Infertility — all drugs for Infertility →
Sponsor
Cairo University
Who can join
Adults 18 to 38, female only, with Recurrent Implantation Failure or Granulocyte Colony-Stimulating Factor. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Intrauterine infusion of granulocyte colony stimulating factor and reproductive outcomes in infertile women with history of recurrent implantation failure
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Granulocyte colony-stimulating factor for recurrent implantation failure: the results of a 5-years cohort study.
Elkhateb I, Fahmy R, Ramadan W, Mourad A, et al · · 2025 · PMID 41254175 · DOI 10.1038/s41598-025-24587-3
Verify or expand the search:
- PubMed search for NCT04998279
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Granulocyte Colony-Stimulating Factor
Trials testing the same drug.
- NCT06752694 — Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult P · Phase 2 · recruiting
- NCT06059391 — CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Unde · Phase 2 · recruiting
- NCT06158828 — Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML · Phase 1, PHASE2 · recruiting
- NCT06034470 — Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK [IMGN632]) for the Treatment of Newly Diagnosed Advers · Phase 1 · active not recruiting
- NCT05907499 — Decitabine for Poor Graft Function Post Allo-HSCT · Phase 3 · not yet recruiting
Other recruiting trials for Recurrent Implantation Failure
Currently open trials in the same condition.
- NCT06762626 — Comparing FET Guided by ERA Vs Standard Timing in Patients with Recurrent Implantation Failure · NA · recruiting
- NCT03900780 — Preimplantation Genetic Testing for Aneuploidies in Patients With Recurrent Implantation Failure · NA · recruiting
- NCT05169541 — Association Between Plasma Level of Mannose Binding Lectin and Human Reproduction · recruiting
Other Cairo University trials
Trials by the same sponsor.
- NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
- NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
- NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
- NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
- NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04998279 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cairo University
- Last refreshed: 1 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04998279.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing